130 related articles for article (PubMed ID: 37339285)
21. Circumferential Resection Margin as Predictor of Nonclinical Complete Response in Nonoperative Management of Rectal Cancer.
Chin RI; Schiff JP; Shetty AS; Pedersen KS; Aranha O; Huang Y; Hunt SR; Glasgow SC; Tan BR; Wise PE; Silviera ML; Smith RK; Suresh R; Byrnes K; Samson PP; Badiyan SN; Henke LE; Mutch MG; Kim H
Dis Colon Rectum; 2023 Jul; 66(7):973-982. PubMed ID: 36876988
[TBL] [Abstract][Full Text] [Related]
22. Effects of Adjuvant Therapy Compliance and Anastomotic Leakage on the Oncologic Outcomes of Patients With Rectal Cancer After Curative Resection.
Fang C; Nie P; Jing P; Zhang Y; Yang L; Yu Y; Wang C; Zhou Z
Dis Colon Rectum; 2021 Jun; 64(6):689-696. PubMed ID: 33394777
[TBL] [Abstract][Full Text] [Related]
23. Nonmicroradical Resection Margin as a Predictor of Recurrence in Patients With Stage III Colon Cancer Undergoing Complete Mesocolic Excision: A Prospective Cohort Study.
Gundestrup AK; Olsen ASF; Ingeholm P; Bols B; Kleif J; Bertelsen CA
Dis Colon Rectum; 2022 May; 65(5):683-691. PubMed ID: 34933419
[TBL] [Abstract][Full Text] [Related]
24. Association of a Preoperative Leisure-Time Physical Activity With Short- and Long-term Outcomes of Patients Undergoing Curative Resection for Stage I to III Colorectal Cancer: A Propensity Score Matching Analysis.
You JF; Hsu YJ; Chern YJ; Hung HY; Hsieh PS; Yeh CY; Chiang JM; Tsai WS
Dis Colon Rectum; 2020 Jun; 63(6):796-806. PubMed ID: 32118625
[TBL] [Abstract][Full Text] [Related]
25. The Prognostic Impact of Preoperative Osteopenia in Patients With Colorectal Cancer.
Kato H; Seishima R; Mizuno S; Matsui S; Shigeta K; Okabayashi K; Kitagawa Y
Dis Colon Rectum; 2023 Dec; 66(12):e1225-e1233. PubMed ID: 37699124
[TBL] [Abstract][Full Text] [Related]
26. Perineural Invasion Is a Prognostic but not a Predictive Factor in Nonmetastatic Colon Cancer.
Leijssen LGJ; Dinaux AM; Taylor MS; Deshpande V; Kunitake H; Bordeianou LG; Berger DL
Dis Colon Rectum; 2019 Oct; 62(10):1212-1221. PubMed ID: 31490830
[TBL] [Abstract][Full Text] [Related]
27. Local Recurrence-Free Survival After TaTME: A Canadian Institutional Experience.
Hershorn O; Ghuman A; Karimuddin AA; Raval MJ; Phang PT; Brown CJ
Dis Colon Rectum; 2024 May; 67(5):664-673. PubMed ID: 38319633
[TBL] [Abstract][Full Text] [Related]
28. The "Classification Pendulum" of Stage I Colorectal Cancer: A National Level Analysis of the Survival Difference Between T1 and T2 Colorectal Cancer.
Allievi N; Goffredo P; Freischlag KW; Utria AF; Cromwell JW; Pisano M; Poiasina E; Hassan I
Dis Colon Rectum; 2022 Apr; 65(4):505-518. PubMed ID: 34310516
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
[TBL] [Abstract][Full Text] [Related]
30. Improved Survival After Adjuvant Therapy in Locally Advanced Rectal Cancer Patients With Pathologic Complete Response.
Lai SH; Vogel JD; Vemuru S; Messersmith W; Lieu C; McCarter MD; Birnbaum E; Chapman BC
Dis Colon Rectum; 2023 Jul; 66(7):983-993. PubMed ID: 36602514
[TBL] [Abstract][Full Text] [Related]
31. Multiple High-Risk Features for Stage II Colon Carcinoma Portends Worse Survival Than Stage III Disease.
Hajirawala LN; Yi Y; Herritt BC; Laurent ME; Klinger AL; Orangio GR; Davis KG; Barton JS
Dis Colon Rectum; 2023 Aug; 66(8):1076-1084. PubMed ID: 35239528
[TBL] [Abstract][Full Text] [Related]
32. Oncologic Outcomes After Transanal Total Mesorectal Excision for Rectal Cancer.
Maykel JA; Hahn SJ; Beauharnais CC; Meyer DC; Hill SS; Sturrock PR; Davids JS; Alavi K
Dis Colon Rectum; 2022 Jun; 65(6):827-836. PubMed ID: 34629431
[TBL] [Abstract][Full Text] [Related]
33. Adverse Oncologic Outcomes of Adenocarcinoma of the Anal Canal in Patients With Crohn's Disease.
Yasuhara M; Beppu N; Uchino M; Ikeuchi H; Matsuda I; Hirota S; Ikeda M; Tomita N
Dis Colon Rectum; 2021 Apr; 64(4):409-419. PubMed ID: 33394780
[TBL] [Abstract][Full Text] [Related]
34. Neoadjuvant Immune Checkpoint Inhibition Improves Organ Preservation in T4bM0 Colorectal Cancer With Mismatch Repair Deficiency: A Retrospective Observational Study.
Han K; Tang JH; Liao LE; Jiang W; Sui QQ; Xiao BY; Li WR; Hong ZG; Li Y; Kong LH; Li DD; Zhang XS; Pan ZZ; Steele SR; Ding PR
Dis Colon Rectum; 2023 Oct; 66(10):e996-e1005. PubMed ID: 35485833
[TBL] [Abstract][Full Text] [Related]
35. Outcomes and Cost Analysis of Robotic Versus Laparoscopic Abdominoperineal Resection for Rectal Cancer: A Case-Matched Study.
Gorgun E; Cengiz TB; Ozgur I; Dionigi B; Kalady MF; Steele SR
Dis Colon Rectum; 2022 Oct; 65(10):1279-1286. PubMed ID: 35195554
[TBL] [Abstract][Full Text] [Related]
36. Mid-transverse Location in Primary Colon Tumor: A Poor Prognostic Factor?
Zenger S; Gurbuz B; Can U; Erginoz E; Ozata IH; Kulle CB; Balik E; Bugra D
Dis Colon Rectum; 2022 Jun; 65(6):817-826. PubMed ID: 34039903
[TBL] [Abstract][Full Text] [Related]
37. Is There a Role for Neoadjuvant Systemic Therapy for cT4bM0 Colon Cancer? A Propensity Score-Matched Analysis of the National Cancer Database.
Kamel MK; Shchatsko A; Keane CA; Serpa E; Al-Qudah G; Rahouma M; Nituica C; Blebea J; Marar O
Dis Colon Rectum; 2023 Nov; 66(11):1435-1448. PubMed ID: 36876973
[TBL] [Abstract][Full Text] [Related]
38. Long-term Oncologic Outcomes of Laparoscopic Anterior Resections for Cancer with Natural Orifice Versus Conventional Specimen Extraction: A Case-Control Study.
Chang SC; Chen HC; Chen YC; Ke TW; Tsai YY; Wang HM; Fingerhut A; Chen WT
Dis Colon Rectum; 2020 Aug; 63(8):1071-1079. PubMed ID: 32692072
[TBL] [Abstract][Full Text] [Related]
39. Robot Surgery Shows Similar Long-term Oncologic Outcomes as Laparoscopic Surgery for Mid/Lower Rectal Cancer but Is Beneficial to ypT3/4 After Preoperative Chemoradiation.
Park SY; Lee SM; Park JS; Kim HJ; Choi GS
Dis Colon Rectum; 2021 Jul; 64(7):812-821. PubMed ID: 33833141
[TBL] [Abstract][Full Text] [Related]
40. Lymphocyte-to-C-Reactive Protein Ratio Is the Most Sensitive Inflammation-Based Prognostic Score in Patients With Unresectable Metastatic Colorectal Cancer.
Nakamura Y; Shida D; Boku N; Yoshida T; Tanabe T; Takamizawa Y; Takashima A; Kanemitsu Y
Dis Colon Rectum; 2021 Nov; 64(11):1331-1341. PubMed ID: 34623347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
